메뉴 건너뛰기




Volumn 14, Issue 8, 2014, Pages 517-534

The tumour microenvironment in B cell lymphomas

Author keywords

[No Author keywords available]

Indexed keywords

B LYMPHOCYTE RECEPTOR; TOLL LIKE RECEPTOR;

EID: 84905055451     PISSN: 1474175X     EISSN: 14741768     Source Type: Journal    
DOI: 10.1038/nrc3774     Document Type: Review
Times cited : (417)

References (203)
  • 2
    • 79958043675 scopus 로고    scopus 로고
    • National Cancer Institute. B ethesda MD [online]
    • Howlader N. et al. SEER Cancer Statistics Review, 1975-2010. National Cancer Institute. B ethesda, MD [online] http://seer.cancer.gov/csr/1975-2010/ (2013
    • (2013) SEER Cancer Statistics Review 1975-2010
    • Howlader, N.1
  • 3
    • 70450190156 scopus 로고    scopus 로고
    • Canadian Cancer Societys Advisory Committee on Cancer Statistics. Canadian Cancer Society
    • Canadian Cancer Societys Advisory Committee on Cancer Statistics. Canadian Cancer Statistics, Toronto, ON. Canadian Cancer Society (2013
    • (2013) Canadian Cancer Statistics, Toronto, on
  • 5
    • 79952284127 scopus 로고    scopus 로고
    • Hallmarks of cancer: The next generation
    • Hanahan, D. & Weinberg, R. A. Hallmarks of cancer: The next generation. Cell 144, 646-674 (2011
    • (2011) Cell , vol.144 , pp. 646-674
    • Hanahan, D.1    Weinberg, R.A.2
  • 6
    • 84867051939 scopus 로고    scopus 로고
    • Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics
    • Schmitz, R. et al. Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics. Nature 490, 116-120 (2012
    • (2012) Nature , vol.490 , pp. 116-120
    • Schmitz, R.1
  • 7
    • 79961158055 scopus 로고    scopus 로고
    • Follicular regulatory T cells expressing Foxp3 and Bcl 6 suppress germinal center reactions
    • Chung, Y. et al. Follicular regulatory T cells expressing Foxp3 and Bcl 6 suppress germinal center reactions. Nature Med. 17, 983-988 (2011
    • (2011) Nature Med , vol.17 , pp. 983-988
    • Chung, Y.1
  • 8
    • 79961151137 scopus 로고    scopus 로고
    • Foxp3+ follicular regulatory T cells control the germinal center response
    • Linterman, M. A. et al. Foxp3+ follicular regulatory T cells control the germinal center response. Nature Med. 17, 975-982 (2011
    • (2011) Nature Med , vol.17 , pp. 975-982
    • Linterman, M.A.1
  • 9
    • 84857883847 scopus 로고    scopus 로고
    • Macrophage plasticity and polarization: In vivo veritas
    • Sica, A. & Mantovani, A. Macrophage plasticity and polarization: In vivo veritas. J. Clin. Invest. 122, 787-795 (2012
    • (2012) J. Clin. Invest , vol.122 , pp. 787-795
    • Sica, A.1    Mantovani, A.2
  • 10
    • 84891535219 scopus 로고    scopus 로고
    • Defining characteristics of classical Hodgkin lymphoma microenvironment T helper cells
    • Greaves, P. et al. Defining characteristics of classical Hodgkin lymphoma microenvironment T helper cells. Blood 122, 2856-2863 (2013
    • (2013) Blood , vol.122 , pp. 2856-2863
    • Greaves, P.1
  • 11
    • 79955877897 scopus 로고    scopus 로고
    • Molecular pathogenesis of Hodgkins lymphoma: Increasing evidence of the importance of the microenvironment
    • Steidl, C., Connors, J. M. & Gascoyne, R. D. Molecular pathogenesis of Hodgkins lymphoma: Increasing evidence of the importance of the microenvironment. J. Clin. Oncol. 29, 1812-1826 (2011
    • (2011) J. Clin. Oncol , vol.29 , pp. 1812-1826
    • Steidl, C.1    Connors, J.M.2    Gascoyne, R.D.3
  • 12
    • 36148999015 scopus 로고    scopus 로고
    • Lymphoma dissemination: The other face of lymphocyte homing
    • DOI 10.1182/blood-2007-05-075176
    • Pals, S. T., De Gorter, D. J. & Spaargaren, M. Lymphoma dissemination: The other face of lymphocyte homing. Blood 110, 3102-3111 (2007 (Pubitemid 350106300)
    • (2007) Blood , vol.110 , Issue.9 , pp. 3102-3111
    • Pals, S.T.1    De Gorter, D.J.J.2    Spaargaren, M.3
  • 14
    • 70349873329 scopus 로고    scopus 로고
    • Identification of a chemokine receptor profile characteristic for mediastinal large B cell lymphoma
    • Rehm, A. et al. Identification of a chemokine receptor profile characteristic for mediastinal large B cell lymphoma. Int. J. Cancer 125, 2367-2374 (2009
    • (2009) Int. J. Cancer , vol.125 , pp. 2367-2374
    • Rehm, A.1
  • 15
    • 79961008660 scopus 로고    scopus 로고
    • Cooperative function of CCR7 and lymphotoxin in the formation of a lymphoma-permissive niche within secondary lymphoid organs
    • Rehm, A. et al. Cooperative function of CCR7 and lymphotoxin in the formation of a lymphoma-permissive niche within secondary lymphoid organs. Blood 118, 1020-1033 (2011
    • (2011) Blood , vol.118 , pp. 1020-1033
    • Rehm, A.1
  • 16
    • 0035073349 scopus 로고    scopus 로고
    • Relative distribution of tumour cells and reactive cells in follicular lymphoma
    • DOI 10.1002/path.820
    • Su, W., Spencer, J. & Wotherspoon, A. C. Relative distribution of tumour cells and reactive cells in follicular lymphoma. J. Pathol. 193, 498-504 (2001 (Pubitemid 32266819)
    • (2001) Journal of Pathology , vol.193 , Issue.4 , pp. 498-504
    • Su, W.1    Spencer, J.2    Wotherspoon, A.C.3
  • 17
    • 0037085793 scopus 로고    scopus 로고
    • Tumor cell dissemination in follicular lymphoma
    • DOI 10.1182/blood.V99.6.2192
    • Oeschger, S., Bräuninger, A., Küppers, R. & Hansmann, M. L. Tumor cell dissemination in follicular lymphoma. Blood 99, 2192-2198 (2002 (Pubitemid 34525506)
    • (2002) Blood , vol.99 , Issue.6 , pp. 2192-2198
    • Oeschger, S.1    Brauninger, A.2    Kuppers, R.3    Hansmann, M.-L.4
  • 18
  • 19
    • 34948875291 scopus 로고    scopus 로고
    • - T cells
    • DOI 10.1182/blood-2007-03-082578
    • Yang, Z. Z., Novak, A. J., Ziesmer, S. C., Witzig, T. E. & Ansell, S. M. CD70+ non-Hodgkin lymphoma B cells induce Foxp3 expression and regulatory function in intratumoral CD4+CD25-T cells. Blood 110, 2537-2544 (2007 (Pubitemid 47523176)
    • (2007) Blood , vol.110 , Issue.7 , pp. 2537-2544
    • Yang, Z.-Z.1    Novak, A.J.2    Ziesmer, S.C.3    Witzig, T.E.4    Ansell, S.M.5
  • 20
    • 58149376998 scopus 로고    scopus 로고
    • Follicular lymphoma B cells induce the conversion of conventional CD4+ T cells to T regulatory cells
    • Ai, W. Z. et al. Follicular lymphoma B cells induce the conversion of conventional CD4+ T cells to T regulatory cells. Int. J. Cancer 124, 239-244 (2009
    • (2009) Int. J. Cancer , vol.124 , pp. 239-244
    • Ai, W.Z.1
  • 21
    • 67650446560 scopus 로고    scopus 로고
    • Malignant B cells skew the balance of regulatory T cells and TH17 cells in B cell non-Hodgkins lymphoma
    • Yang, Z. Z., Novak, A. J., Ziesmer, S. C., Witzig, T. E. & Ansell, S. M. Malignant B cells skew the balance of regulatory T cells and TH17 cells in B cell non-Hodgkins lymphoma. Cancer Res. 69, 5522-5530 (2009
    • (2009) Cancer Res , vol.69 , pp. 5522-5530
    • Yang, Z.Z.1    Novak, A.J.2    Ziesmer, S.C.3    Witzig, T.E.4    Ansell, S.M.5
  • 23
    • 33646422454 scopus 로고    scopus 로고
    • Intratumoral CD4+CD25+ regulatory T cell-mediated suppression of infiltrating CD4+ T cells in B cell non-Hodgkin lymphoma
    • Yang, Z. Z., Novak, A. J., Stenson, M. J., Witzig, T. E. & Ansell, S. M. Intratumoral CD4+CD25+ regulatory T cell-mediated suppression of infiltrating CD4+ T cells in B cell non-Hodgkin lymphoma. Blood 107, 3639-3646 (2006
    • (2006) Blood , vol.107 , pp. 3639-3646
    • Yang, Z.Z.1    Novak, A.J.2    Stenson, M.J.3    Witzig, T.E.4    Ansell, S.M.5
  • 24
    • 84858626097 scopus 로고    scopus 로고
    • Mesenchymal stromal cells orchestrate follicular lymphoma cell niche through the CCL2 dependent recruitment and polarization of monocytes
    • Guilloton, F. et al. Mesenchymal stromal cells orchestrate follicular lymphoma cell niche through the CCL2 dependent recruitment and polarization of monocytes. Blood 119, 2556-2567 (2012
    • (2012) Blood , vol.119 , pp. 2556-2567
    • Guilloton, F.1
  • 25
    • 1842413105 scopus 로고    scopus 로고
    • The non-hodgkins lymphoma classification project A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkins lymphoma
    • The Non-Hodgkins Lymphoma Classification Project. A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkins lymphoma. Blood 89, 3909-3918 (1997
    • (1997) Blood , vol.89 , pp. 3909-3918
  • 26
    • 0036110314 scopus 로고    scopus 로고
    • The stromal composition of malignant lymphoid aggregates in bone marrow: Variations in architecture and phenotype in different B-cell tumours
    • DOI 10.1046/j.1365-2141.2002.03497.x
    • Vega, F. et al. The stromal composition of malignant lymphoid aggregates in bone marrow: Variations in architecture and phenotype in different B cell tumours. Br. J. Haematol. 117, 569-576 (2002 (Pubitemid 34539230)
    • (2002) British Journal of Haematology , vol.117 , Issue.3 , pp. 569-576
    • Vega, F.1    Medeiros, L.J.2    Lang, W.-H.3    Mansoor, A.4    Bueso-Ramos, C.5    Jones, D.6
  • 27
    • 84860347823 scopus 로고    scopus 로고
    • Impact of the reactive microenvironment on the bone marrow involvement of follicular lymphoma
    • Rajnai, H. et al. Impact of the reactive microenvironment on the bone marrow involvement of follicular lymphoma. Histopathology 60, E66-E75 (2012
    • (2012) Histopathology , vol.60
    • Rajnai, H.1
  • 28
    • 0035999150 scopus 로고    scopus 로고
    • Chronic B cell malignancies and bone marrow microenvironment
    • DOI 10.1006/scbi.2001.0423
    • Ghia, P., Granziero, L., Chilosi, M. & Caligaris-Cappio, F. Chronic B cell malignancies and bone marrow microenvironment. Semin. Cancer Biol. 12, 149-155 (2002 (Pubitemid 34680744)
    • (2002) Seminars in Cancer Biology , vol.12 , Issue.2 , pp. 149-155
    • Ghia, P.1    Granziero, L.2    Chilosi, M.3    Caligaris-Cappio, F.4
  • 29
    • 57749171165 scopus 로고    scopus 로고
    • The biology of Hodgkins lymphoma
    • Küppers, R. The biology of Hodgkins lymphoma. Nature Rev. Cancer 9, 15-27 (2008
    • (2008) Nature Rev. Cancer , vol.9 , pp. 15-27
    • Küppers, R.1
  • 30
    • 0023191121 scopus 로고
    • The presence of clonogenic cells in high-grade malignant lymphoma: A prognostic factor
    • Tweeddale, M. E. et al. The presence of clonogenic cells in high-grade malignant lymphoma: A prognostic factor. Blood 69, 1307-1314 (1987 (Pubitemid 17085284)
    • (1987) Blood , vol.69 , Issue.5 , pp. 1307-1314
    • Tweeddale, M.E.1    Lim, B.2    Jamal, N.3
  • 31
    • 0027170870 scopus 로고
    • The response of cells from low-grade B-cell gastric lymphomas of mucosa-associated lymphoid tissue to Helicobacter pylori
    • DOI 10.1016/0140-6736(93)91408-E
    • Hussell, T., Isaacson, P. G., Crabtree, J. E. & Spencer, J. The response of cells from low-grade B cell gastric lymphomas of mucosa-Associated lymphoid tissue to Helicobacter pylori. Lancet 342, 571-574 (1993 (Pubitemid 23259232)
    • (1993) Lancet , vol.342 , Issue.8871 , pp. 571-574
    • Hussell, T.1    Isaacson, P.G.2    Crabtree, J.E.3    Spencer, J.4
  • 33
    • 0025217133 scopus 로고
    • + T cell clones
    • Umetsu, D. T., Esserman, L., Donlon, T. A., DeKruyff, R. H. & Levy, R. Induction of proliferation of human follicular (B type) lymphoma cells by cognate interaction with CD4+ T cell clones. J. Immunol. 144, 2550-2557 (1990 (Pubitemid 20136656)
    • (1990) Journal of Immunology , vol.144 , Issue.7 , pp. 2550-2557
    • Umetsu, D.T.1    Esserman, L.2    Donlon, T.A.3    Dekruyff, R.H.4    Levy, R.5
  • 34
    • 0027292644 scopus 로고
    • Isolated follicular lymphoma cells are resistant to apoptosis and can be grown in vitro in the CD40/stromal cell system
    • Johnson, P. W. M. et al. Isolated follicular lymphoma cells are resistant to apoptosis and can be grown in vitro in the CD40/stromal cell system. Blood 82, 1848-1857 (1993 (Pubitemid 23278776)
    • (1993) Blood , vol.82 , Issue.6 , pp. 1848-1857
    • Johnson, P.W.M.1    Watt, S.M.2    Betts, D.R.3    Davies, D.4    Jordan, S.5    Norton, A.J.6    Lister, T.A.7
  • 35
    • 0342711256 scopus 로고    scopus 로고
    • In vivo ablation of surface immunoglobulin on mature B cells by inducible gene targeting results in rapid cell death
    • DOI 10.1016/S0092-8674(00)80373-6
    • Lam, K. P., Kn, R. & Rajewsky, K. In vivo ablation of surface immunoglobulin on mature B cells by inducible gene targeting results in rapid cell death. Cell 90, 1073-1083 (1997 (Pubitemid 27408521)
    • (1997) Cell , vol.90 , Issue.6 , pp. 1073-1083
    • Lam, K.-P.1    Kuhn, R.2    Rajewsky, K.3
  • 36
    • 2942582913 scopus 로고    scopus 로고
    • Survival of resting mature B lymphocytes depends on BCR signaling via the Igα/β heterodimer
    • DOI 10.1016/j.cell.2004.05.014, PII S0092867404005306
    • Kraus, M., Alimzhanov, M. B., Rajewsky, N. & Rajewsky, K. Survival of resting mature B lymphocytes depends on BCR signaling via the Igα/β heterodimer. Cell 117, 787-800 (2004 (Pubitemid 38748894)
    • (2004) Cell , vol.117 , Issue.6 , pp. 787-800
    • Kraus, M.1    Alimzhanov, M.B.2    Rajewsky, N.3    Rajewsky, K.4
  • 37
    • 70350304558 scopus 로고    scopus 로고
    • PI3 kinase signals BCR-dependent mature B cell survival
    • Srinivasan, L. et al. PI3 kinase signals BCR-dependent mature B cell survival. Cell 139, 573-586 (2009
    • (2009) Cell , vol.139 , pp. 573-586
    • Srinivasan, L.1
  • 38
    • 16844381831 scopus 로고    scopus 로고
    • Mechanisms of B cell lymphoma pathogenesis
    • Küppers, R. Mechanisms of B cell lymphoma pathogenesis. Nature Rev. Cancer 5, 251-262 (2005
    • (2005) Nature Rev. Cancer , vol.5 , pp. 251-262
    • Küppers, R.1
  • 39
    • 0021792138 scopus 로고
    • Spontaneous alteration of idiotype in a monoclonal B-cell lymphoma. Escape from detection by anti-idiotype
    • Raffeld, M., Neckers, L., Longo, D. L. & Cossman, J. Spontaneous alteration of idiotype in a monoclonal B cell lymphoma-escape from detection by anti-idiotype. N. Engl. J. Med. 312, 1653-1658 (1985 (Pubitemid 15068571)
    • (1985) New England Journal of Medicine , vol.312 , Issue.26 , pp. 1653-1658
    • Raffeld, M.1    Neckers, L.2    Longo, D.L.3    Cossman, J.4
  • 40
    • 0021792139 scopus 로고
    • Emergence of idiotype variants during treatment of B-cell lymphoma with anti-idiotype antibodies
    • Meeker, T. et al. Emergence of idiotype variants during treatment of B cell lymphoma with anti-idiotype antibodies. N. Engl. J. Med. 312, 1658-1665 (1985 (Pubitemid 15068572)
    • (1985) New England Journal of Medicine , vol.312 , Issue.26 , pp. 1658-1665
    • Meeker, T.1    Lowder, J.2    Cleary, M.L.3
  • 41
    • 84869752792 scopus 로고    scopus 로고
    • Self-Antigen recognition by follicular lymphoma B cell receptors
    • Sachen, K. L. et al. Self-Antigen recognition by follicular lymphoma B cell receptors. Blood 120, 4182-4190 (2012
    • (2012) Blood , vol.120 , pp. 4182-4190
    • Sachen, K.L.1
  • 42
    • 84876798571 scopus 로고    scopus 로고
    • Nonstereotyped lymphoma B cell receptors recognize vimentin as a shared autoantigen
    • Cha, S. C. et al. Nonstereotyped lymphoma B cell receptors recognize vimentin as a shared autoantigen. J. Immunol. 190, 4887-4898 (2013
    • (2013) J. Immunol , vol.190 , pp. 4887-4898
    • Cha, S.C.1
  • 43
    • 77449108587 scopus 로고    scopus 로고
    • Gastric MALT lymphoma B cell express polyreactive, somatically mutated immunoglobulins
    • Craig, V. J. et al. Gastric MALT lymphoma B cell express polyreactive, somatically mutated immunoglobulins. Blood 115, 581-591 (2010
    • (2010) Blood , vol.115 , pp. 581-591
    • Craig, V.J.1
  • 44
    • 18244385722 scopus 로고    scopus 로고
    • Among B cell non-Hodgkin's lymphomas, MALT lymphomas express a unique antibody repertoire with frequent rheumatoid factor reactivity
    • DOI 10.1084/jem.20050068
    • Bende, R. J. et al. Among B cell non-Hodgkins lymphomas, MALT lymphomas express a unique antibody repertoire with frequent rheumatoid factor reactivity. J. Exp. Med. 201, 1229-1241 (2005 (Pubitemid 40629067)
    • (2005) Journal of Experimental Medicine , vol.201 , Issue.8 , pp. 1229-1241
    • Bende, R.J.1    Aarts, W.M.2    Riedl, R.G.3    De Jong, D.4    Pals, S.T.5    Van Noesel, C.J.M.6
  • 45
    • 80052929598 scopus 로고    scopus 로고
    • Is there a role for antigen selection in mantle cell lymphoma?. Immunogenetic support from a series of 807 cases
    • Hadzidimitriou, A. et al. Is there a role for antigen selection in mantle cell lymphoma?. Immunogenetic support from a series of 807 cases. Blood 118, 3088-3095 (2011
    • (2011) Blood , vol.118 , pp. 3088-3095
    • Hadzidimitriou, A.1
  • 46
    • 0036530010 scopus 로고    scopus 로고
    • Acquisition of potential N-glycosylation sites in the immunoglobulin variable region by somatic mutation is a distinctive feature of follicular lymphoma
    • DOI 10.1182/blood.V99.7.2562
    • Zhu, D. et al. Acquisition of potential N glycosylation sites in the immunoglobulin variable region by somatic mutation is a distinctive feature of follicular lymphoma. Blood 99, 2562-2568 (2002 (Pubitemid 34525446)
    • (2002) Blood , vol.99 , Issue.7 , pp. 2562-2568
    • Zhu, D.1    McCarthy, H.2    Ottensmeier, C.H.3    Johnson, P.4    Hamblin, T.J.5    Stevenson, F.K.6
  • 47
    • 78649840358 scopus 로고    scopus 로고
    • Glycosylation of surface Ig creates a functional bridge between human follicular lymphoma and microenvironmental lectins
    • Coelho, V. et al. Glycosylation of surface Ig creates a functional bridge between human follicular lymphoma and microenvironmental lectins. Proc. Natl Acad. Sci. USA 107, 18587-18592 (2010
    • (2010) Proc. Natl Acad. Sci. USA , vol.107 , pp. 18587-18592
    • Coelho, V.1
  • 49
    • 80053449635 scopus 로고    scopus 로고
    • Early steps of follicular lymphoma pathogenesis
    • Roulland, S. et al. Early steps of follicular lymphoma pathogenesis. Adv. Immunol. 111, 1-46 (2011
    • (2011) Adv. Immunol , vol.111 , pp. 1-46
    • Roulland, S.1
  • 50
    • 84860346868 scopus 로고    scopus 로고
    • Follicular lymphoma and the immune system: From pathogenesis to antibody therapy
    • Stevenson, F. K. & Stevenson, G. T. Follicular lymphoma and the immune system: From pathogenesis to antibody therapy. Blood 119, 3659-3667 (2012
    • (2012) Blood , vol.119 , pp. 3659-3667
    • Stevenson, F.K.1    Stevenson, G.T.2
  • 52
    • 73849145729 scopus 로고    scopus 로고
    • Chronic active B cell-receptor signalling in diffuse large B cell lymphoma
    • Davis, R. E. et al. Chronic active B cell-receptor signalling in diffuse large B cell lymphoma. Nature 463, 88-92 (2010
    • (2010) Nature , vol.463 , pp. 88-92
    • Davis, R.E.1
  • 54
    • 79551686422 scopus 로고    scopus 로고
    • Oncogenically active MYD88 mutations in human lymphoma
    • Ngo, V. N. et al. Oncogenically active MYD88 mutations in human lymphoma. Nature 470, 115-119 (2010
    • (2010) Nature , vol.470 , pp. 115-119
    • Ngo, V.N.1
  • 55
    • 84866429139 scopus 로고    scopus 로고
    • The coding genome of splenic marginal zone lymphoma: Activation of NOTCH2 and other pathways regulating marginal zone development
    • Rossi, D. et al. The coding genome of splenic marginal zone lymphoma: Activation of NOTCH2 and other pathways regulating marginal zone development. J. Exp. Med. 209, 1537-1551 (2012
    • (2012) J. Exp. Med , vol.209 , pp. 1537-1551
    • Rossi, D.1
  • 56
    • 84859450196 scopus 로고    scopus 로고
    • BCR and TLR signaling pathways are recurrently targeted by genetic changes in splenic marginal zone lymphomas
    • Yan, Q. et al. BCR and TLR signaling pathways are recurrently targeted by genetic changes in splenic marginal zone lymphomas. Haematologica 97, 595-598 (2012
    • (2012) Haematologica , vol.97 , pp. 595-598
    • Yan, Q.1
  • 57
    • 84865475885 scopus 로고    scopus 로고
    • MYD88 L265P somatic mutation in Waldenstroms macroglobulinemia
    • Treon, S. P. et al. MYD88 L265P somatic mutation in Waldenstroms macroglobulinemia. N. Engl. J. Med. 367, 826-833 (2012
    • (2012) N. Engl. J. Med , vol.367 , pp. 826-833
    • Treon, S.P.1
  • 58
    • 84896814479 scopus 로고    scopus 로고
    • Consequences of the recurrent MYD88L265P somatic mutation for B cell tolerance
    • Wang, J. Q., Jeelall, Y. S., Beutler, B., Horikawa, K. & Goodnow, C. C. Consequences of the recurrent MYD88L265P somatic mutation for B cell tolerance. J. Exp. Med. 211, 413-426 (2014
    • (2014) J. Exp. Med , vol.211 , pp. 413-426
    • Wang, J.Q.1    Jeelall, Y.S.2    Beutler, B.3    Horikawa, K.4    Goodnow, C.C.5
  • 59
    • 78650309840 scopus 로고    scopus 로고
    • Follicular lymphoma cell niche: Identification of a preeminent IL 4 dependent TFH B cell axis
    • Pangault, C. et al. Follicular lymphoma cell niche: Identification of a preeminent IL 4 dependent TFH B cell axis. Leukemia 24, 2080-2089 (2010
    • (2010) Leukemia , vol.24 , pp. 2080-2089
    • Pangault, C.1
  • 60
    • 55749114922 scopus 로고    scopus 로고
    • IL 4 protein expression and basal activation of Erk in vivo in follicular lymphoma
    • Calvo, K. R. et al. IL 4 protein expression and basal activation of Erk in vivo in follicular lymphoma. Blood 112, 3818-3826 (2008
    • (2008) Blood , vol.112 , pp. 3818-3826
    • Calvo, K.R.1
  • 61
    • 84856708321 scopus 로고    scopus 로고
    • Monocytes and T cells cooperate to favor normal and follicular lymphoma B cell growth: Role of IL 15 and CD40L signaling
    • Epron, G. et al. Monocytes and T cells cooperate to favor normal and follicular lymphoma B cell growth: Role of IL 15 and CD40L signaling. Leukemia 26, 139-148 (2012
    • (2012) Leukemia , vol.26 , pp. 139-148
    • Epron, G.1
  • 63
    • 41949138741 scopus 로고    scopus 로고
    • APRIL is critical for plasmablast survival in the bone marrow and poorly expressed by early-life bone marrow stromal cells
    • Belnoue, E. et al. APRIL is critical for plasmablast survival in the bone marrow and poorly expressed by early-life bone marrow stromal cells. Blood 111, 2755-2764 (2008
    • (2008) Blood , vol.111 , pp. 2755-2764
    • Belnoue, E.1
  • 64
    • 79959196668 scopus 로고    scopus 로고
    • Tumor-Associated macrophages as major source of APRIL in gastric MALT lymphoma
    • Munari, F. et al. Tumor-Associated macrophages as major source of APRIL in gastric MALT lymphoma. Blood 117, 6612-6616 (2011
    • (2011) Blood , vol.117 , pp. 6612-6616
    • Munari, F.1
  • 67
    • 14044259331 scopus 로고    scopus 로고
    • Enhanced apoptotic cell clearance capacity and B cell survival factor production by IL-10-activated macrophages: Implications for Burkitt's lymphoma
    • Ogden, C. A. et al. Enhanced apoptotic cell clearance capacity and B cell survival factor production by IL 10 activated macrophages: Implications for Burkitts lymphoma. J. Immunol. 174, 3015-3023 (2005 (Pubitemid 40279722)
    • (2005) Journal of Immunology , vol.174 , Issue.5 , pp. 3015-3023
    • Ogden, C.A.1    Pound, J.D.2    Batth, B.K.3    Owens, S.4    Johannessen, I.5    Wood, K.6    Gregory, C.D.7
  • 69
    • 58249102301 scopus 로고    scopus 로고
    • Lymphoma cell adhesion-induced expression of B cell-Activating factor of the TNF family in bone marrow stromal cells protects non-Hodgkins B lymphoma cells from apoptosis
    • Lwin, T. et al. Lymphoma cell adhesion-induced expression of B cell-Activating factor of the TNF family in bone marrow stromal cells protects non-Hodgkins B lymphoma cells from apoptosis. Leukemia 23, 170-177 (2009
    • (2009) Leukemia , vol.23 , pp. 170-177
    • Lwin, T.1
  • 70
    • 33846255324 scopus 로고    scopus 로고
    • Human mesenchymal stem cells isolated from bone marrow and lymphoid organs support tumor B cell growth: Role of stromal cells in follicular lymphoma pathogenesis
    • Am-Thomas, P. et al. Human mesenchymal stem cells isolated from bone marrow and lymphoid organs support tumor B cell growth: Role of stromal cells in follicular lymphoma pathogenesis. Blood 109, 693-702 (2007
    • (2007) Blood , vol.109 , pp. 693-702
    • Am-Thomas, P.1
  • 71
    • 84864779051 scopus 로고    scopus 로고
    • Mesenchymal stromal cells protect mantle cell lymphoma cells from spontaneous and drug-induced apoptosis through secretion of B cell activating factor and activation of the canonical and non-canonical nuclear factor κb pathways
    • Medina, D. J. et al. Mesenchymal stromal cells protect mantle cell lymphoma cells from spontaneous and drug-induced apoptosis through secretion of B cell activating factor and activation of the canonical and non-canonical nuclear factor κB pathways. Haematologica 97, 1255-1263 (2012
    • (2012) Haematologica , vol.97 , pp. 1255-1263
    • Medina, D.J.1
  • 73
    • 77952420404 scopus 로고    scopus 로고
    • Hedgehog signaling pathway is activated in diffuse large B cell lymphoma and contributes to tumor cell survival and proliferation
    • Singh, R. R. et al. Hedgehog signaling pathway is activated in diffuse large B cell lymphoma and contributes to tumor cell survival and proliferation. Leukemia 24, 1025-1036 (2010
    • (2010) Leukemia , vol.24 , pp. 1025-1036
    • Singh, R.R.1
  • 74
    • 70349694160 scopus 로고    scopus 로고
    • Sonic hedgehog signaling proteins and ATP-binding cassette G2 are aberrantly expressed in diffuse large B cell lymphoma
    • Kim, J. E. et al. Sonic hedgehog signaling proteins and ATP-binding cassette G2 are aberrantly expressed in diffuse large B cell lymphoma. Mod. Pathol. 22, 1312-1320 (2009
    • (2009) Mod. Pathol , vol.22 , pp. 1312-1320
    • Kim, J.E.1
  • 75
    • 0034669309 scopus 로고    scopus 로고
    • Extensive genetic alterations of the HLA region, including homozygous deletions of HLA class II genes in B cell lymphomas arising in immune-privileged sites
    • Riemersma, S. A. et al. Extensive genetic alterations of the HLA region, including homozygous deletions of HLA class II genes in B cell lymphomas arising in immune-privileged sites. Blood 96, 3569-3577 (2000
    • (2000) Blood , vol.96 , pp. 3569-3577
    • Riemersma, S.A.1
  • 76
    • 79952816655 scopus 로고    scopus 로고
    • MHC class II transactivator CIITA is a recurrent gene fusion partner in lymphoid cancers
    • Steidl, C. et al. MHC class II transactivator CIITA is a recurrent gene fusion partner in lymphoid cancers. Nature 471, 377-381 (2011
    • (2011) Nature , vol.471 , pp. 377-381
    • Steidl, C.1
  • 77
    • 84856882081 scopus 로고    scopus 로고
    • Partial plasma cell differentiation as a mechanism of lost major histocompatibility complex class II expression in diffuse large B cell lymphoma
    • Wilkinson, S. T. et al. Partial plasma cell differentiation as a mechanism of lost major histocompatibility complex class II expression in diffuse large B cell lymphoma. Blood 119, 1459-1467 (2011
    • (2011) Blood , vol.119 , pp. 1459-1467
    • Wilkinson, S.T.1
  • 79
    • 83555173561 scopus 로고    scopus 로고
    • Combined genetic inactivation of β2 Microglobulin and CD58 reveals frequent escape from immune recognition in diffuse large B cell lymphoma
    • Challa-Malladi, M. et al. Combined genetic inactivation of β2 Microglobulin and CD58 reveals frequent escape from immune recognition in diffuse large B cell lymphoma. Cancer Cell 20, 728-740 (2011
    • (2011) Cancer Cell , vol.20 , pp. 728-740
    • Challa-Malladi, M.1
  • 80
    • 80052269038 scopus 로고    scopus 로고
    • Analysis of the coding genome of diffuse large B cell lymphoma
    • Pasqualucci, L. et al. Analysis of the coding genome of diffuse large B cell lymphoma. Nature Genet. 43, 830-837 (2011
    • (2011) Nature Genet , vol.43 , pp. 830-837
    • Pasqualucci, L.1
  • 81
    • 80052029516 scopus 로고    scopus 로고
    • Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma
    • Morin, R. D. et al. Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma. Nature 476, 298-303 (2011
    • (2011) Nature , vol.476 , pp. 298-303
    • Morin, R.D.1
  • 83
    • 78049370405 scopus 로고    scopus 로고
    • Integrative analysis reveals selective 9p24.1 amplification, increased PD 1 ligand expression, and further induction via JAK2 in nodular sclerosing Hodgkin lymphoma and primary mediastinal large B cell lymphoma
    • Green, M. R. et al. Integrative analysis reveals selective 9p24.1 amplification, increased PD 1 ligand expression, and further induction via JAK2 in nodular sclerosing Hodgkin lymphoma and primary mediastinal large B cell lymphoma. Blood 116, 3268-3277 (2010
    • (2010) Blood , vol.116 , pp. 3268-3277
    • Green, M.R.1
  • 84
    • 77955866440 scopus 로고    scopus 로고
    • Genome-wide copy number analysis of Hodgkin Reed-Sternberg cells identifies recurrent imbalances with correlations to treatment outcome
    • Steidl, C. et al. Genome-wide copy number analysis of Hodgkin Reed-Sternberg cells identifies recurrent imbalances with correlations to treatment outcome. Blood 116, 418-427 (2010
    • (2010) Blood , vol.116 , pp. 418-427
    • Steidl, C.1
  • 87
    • 73949116990 scopus 로고    scopus 로고
    • Follicular lymphoma cell induce T cell immunologic synapse dysfunction that can be repaired with lenalidomide: Implications for the tumor microenvironment and immunotherapy
    • Ramsay, A. G. et al. Follicular lymphoma cell induce T cell immunologic synapse dysfunction that can be repaired with lenalidomide: Implications for the tumor microenvironment and immunotherapy. Blood 114, 4713-4720 (2009
    • (2009) Blood , vol.114 , pp. 4713-4720
    • Ramsay, A.G.1
  • 88
    • 84890531605 scopus 로고    scopus 로고
    • Follicular lymphoma cells induce changes in T cell gene expression and function: Potential impact on survival and risk of transformation
    • Kiaii, S. et al. Follicular lymphoma cells induce changes in T cell gene expression and function: Potential impact on survival and risk of transformation. J. Clin. Oncol. 31, 2654-2661 (2013
    • (2013) J. Clin. Oncol , vol.31 , pp. 2654-2661
    • Kiaii, S.1
  • 89
    • 33750535641 scopus 로고    scopus 로고
    • + regulatory T cells in B-cell non-Hodgkin's lymphoma
    • DOI 10.1158/0008-5472.CAN-06-1822
    • Yang, Z. Z., Novak, A. J., Ziesmer, S. C., Witzig, T. E. & Ansell, S. M. Attenuation of CD8+ T cell function by CD4+CD25+ regulatory T cells in B cell non-Hodgkins lymphoma. Cancer Res. 66, 10145-10152 (2006 (Pubitemid 44672069)
    • (2006) Cancer Research , vol.66 , Issue.20 , pp. 10145-10152
    • Yang, Z.-Z.1    Novak, A.J.2    Ziesmer, S.C.3    Witzig, T.E.4    Ansell, S.M.5
  • 90
    • 84860747727 scopus 로고    scopus 로고
    • Characterization of intratumoral follicular helper T cells in follicular lymphoma: Role in the survival of malignant B cells
    • Amé-Thomas, P. et al. Characterization of intratumoral follicular helper T cells in follicular lymphoma: Role in the survival of malignant B cells. Leukemia 26, 1053-1063 (2012
    • (2012) Leukemia , vol.26 , pp. 1053-1063
    • Amé-Thomas, P.1
  • 91
    • 77950950894 scopus 로고    scopus 로고
    • Macrophage diversity enhances tumor progression and metastasis
    • Qian, B. Z. & Pollard, J. W. Macrophage diversity enhances tumor progression and metastasis. Cell 141, 39-51 (2010
    • (2010) Cell , vol.141 , pp. 39-51
    • Qian, B.Z.1    Pollard, J.W.2
  • 93
    • 63849185609 scopus 로고    scopus 로고
    • Molecular profiling of classical Hodgkin lymphoma tissues uncovers variations in the tumor microenvironment and correlations with EBV infection and outcome
    • Chetaille, B. et al. Molecular profiling of classical Hodgkin lymphoma tissues uncovers variations in the tumor microenvironment and correlations with EBV infection and outcome. Blood 113, 2765-2775 (2009
    • (2009) Blood , vol.113 , pp. 2765-2775
    • Chetaille, B.1
  • 94
    • 77949345555 scopus 로고    scopus 로고
    • Tumor-Associated macrophages and survival in classic Hodgkins lymphoma
    • Steidl, C. et al. Tumor-Associated macrophages and survival in classic Hodgkins lymphoma. N. Engl. J. Med. 362, 875-885 (2010
    • (2010) N. Engl. J. Med , vol.362 , pp. 875-885
    • Steidl, C.1
  • 95
    • 57149089307 scopus 로고    scopus 로고
    • Stromal gene signatures in large B cell lymphomas
    • Lenz, G. et al. Stromal gene signatures in large B cell lymphomas. N. Engl. J. Med. 359, 2313-2323 (2008
    • (2008) N. Engl. J. Med , vol.359 , pp. 2313-2323
    • Lenz, G.1
  • 98
    • 38049022492 scopus 로고    scopus 로고
    • The ratio of FOXP3+ regulatory T cells to granzyme B+ cytotoxic T/NK cells predicts prognosis in classical Hodgkin lymphoma and is independent of bcl 2 and MAL expression
    • Kelley, T. W., Pohlman, B., Elson, P. & Hsi, E. D. The ratio of FOXP3+ regulatory T cells to granzyme B+ cytotoxic T/NK cells predicts prognosis in classical Hodgkin lymphoma and is independent of bcl 2 and MAL expression. Am. J. Clin. Pathol. 128, 958-965 (2007
    • (2007) Am. J. Clin. Pathol , vol.128 , pp. 958-965
    • Kelley, T.W.1    Pohlman, B.2    Elson, P.3    Hsi, E.D.4
  • 99
    • 0036187615 scopus 로고    scopus 로고
    • The role of tumour-associated macrophages in tumour progression: Implications for new anticancer therapies
    • DOI 10.1002/path.1027
    • Bingle, L., Brown, N. J. & Lewis, C. E. The role of tumour-Associated macrophages in tumour progression: Implications for new anticancer therapies. J. Pathol. 196, 254-265 (2002 (Pubitemid 34189413)
    • (2002) Journal of Pathology , vol.196 , Issue.3 , pp. 254-265
    • Bingle, L.1    Brown, N.J.2    Lewis, C.E.3
  • 100
  • 101
    • 77956544224 scopus 로고    scopus 로고
    • A molecular risk score based on 4 functional pathways for advanced classical Hodgkin lymphoma
    • Sánchez-Espiridión, B. et al. A molecular risk score based on 4 functional pathways for advanced classical Hodgkin lymphoma. Blood 116, e12-e17 (2010
    • (2010) Blood , vol.116
    • Sánchez-Espiridión, B.1
  • 102
    • 84875743842 scopus 로고    scopus 로고
    • Gene expression-based model using formalin-fixed paraffin-embedded biopsies predicts overall survival in advanced-stage classical Hodgkin lymphoma
    • Scott, D. W. et al. Gene expression-based model using formalin-fixed paraffin-embedded biopsies predicts overall survival in advanced-stage classical Hodgkin lymphoma. J. Clin. Oncol. 31, 692-700 (2013
    • (2013) J. Clin. Oncol , vol.31 , pp. 692-700
    • Scott, D.W.1
  • 103
    • 79251502962 scopus 로고    scopus 로고
    • The stromal cell marker SPARC predicts for survival in patients with diffuse large B cell lymphoma treated with rituximab
    • Meyer, P. N. et al. The stromal cell marker SPARC predicts for survival in patients with diffuse large B cell lymphoma treated with rituximab. Am. J. Clin. Pathol. 135, 54-61 (2011
    • (2011) Am. J. Clin. Pathol , vol.135 , pp. 54-61
    • Meyer, P.N.1
  • 104
    • 79959944338 scopus 로고    scopus 로고
    • High microvessel density determines a poor outcome in patients with diffuse large B cell lymphoma treated with rituximab plus chemotherapy
    • Cardesa-Salzmann, T. M. et al. High microvessel density determines a poor outcome in patients with diffuse large B cell lymphoma treated with rituximab plus chemotherapy. Haematologica 96, 996-1001 (2011
    • (2011) Haematologica , vol.96 , pp. 996-1001
    • Cardesa-Salzmann, T.M.1
  • 105
    • 58149242769 scopus 로고    scopus 로고
    • Impact of the tumor microenvironment on prognosis in follicular lymphoma is dependent on specific treatment protocols
    • De Jong, D. et al. Impact of the tumor microenvironment on prognosis in follicular lymphoma is dependent on specific treatment protocols. Haematologica 94, 70-77 (2009
    • (2009) Haematologica , vol.94 , pp. 70-77
    • De Jong, D.1
  • 106
    • 77955386082 scopus 로고    scopus 로고
    • Implications of the tumor microenvironment on survival and disease response in follicular lymphoma
    • Gribben, J. G. Implications of the tumor microenvironment on survival and disease response in follicular lymphoma. Curr. Opin. Oncol. 22, 424-430 (2010
    • (2010) Curr. Opin. Oncol , vol.22 , pp. 424-430
    • Gribben, J.G.1
  • 107
    • 84867148654 scopus 로고    scopus 로고
    • Pathogenesis of follicular lymphoma
    • Kridel, R., Sehn, L. H. & Gascoyne, R. D. Pathogenesis of follicular lymphoma. J. Clin. Invest. 122, 3424-3431 (2012
    • (2012) J. Clin. Invest , vol.122 , pp. 3424-3431
    • Kridel, R.1    Sehn, L.H.2    Gascoyne, R.D.3
  • 108
    • 84897402974 scopus 로고    scopus 로고
    • The reliability of immunohistochemical analysis of the tumor microenvironment in follicular lymphoma: A validation study from the Lunenburg Lymphoma Biomarker Consortium
    • Sander, B. et al. The reliability of immunohistochemical analysis of the tumor microenvironment in follicular lymphoma: A validation study from the Lunenburg Lymphoma Biomarker Consortium. Haematologica 99, 715-725 (2014
    • (2014) Haematologica , vol.99 , pp. 715-725
    • Sander, B.1
  • 110
    • 53449095327 scopus 로고    scopus 로고
    • Host immune gene polymorphisms in combination with clinical and demographic factors predict late survival in diffuse large B cell lymphoma patients in the pre-rituximab era
    • Habermann, T. M. et al. Host immune gene polymorphisms in combination with clinical and demographic factors predict late survival in diffuse large B cell lymphoma patients in the pre-rituximab era. Blood 112, 2694-2702 (2008
    • (2008) Blood , vol.112 , pp. 2694-2702
    • Habermann, T.M.1
  • 111
    • 84885189071 scopus 로고    scopus 로고
    • Cytokine gene polymorphisms and progression-free survival in classical Hodgkin lymphoma by EBV status: Results from two independent cohorts
    • Ghesquieres, H. et al. Cytokine gene polymorphisms and progression-free survival in classical Hodgkin lymphoma by EBV status: Results from two independent cohorts. Cytokine 64, 523-531 (2013
    • (2013) Cytokine , vol.64 , pp. 523-531
    • Ghesquieres, H.1
  • 112
    • 84875174768 scopus 로고    scopus 로고
    • The role of tumour-stromal interactions in modifying drug response: Challenges and opportunities
    • McMillin, D. W., Negri, J. M. & Mitsiades, C. S. The role of tumour-stromal interactions in modifying drug response: Challenges and opportunities. Nature Rev. Drug Discov. 12, 217-228 (2013
    • (2013) Nature Rev. Drug Discov , vol.12 , pp. 217-228
    • McMillin, D.W.1    Negri, J.M.2    Mitsiades, C.S.3
  • 113
    • 34250788040 scopus 로고    scopus 로고
    • Bone marrow stromal cells prevent apoptosis of lymphoma cells by upregulation of anti-apoptotic proteins associated with activation of NF-κB (RelB/p52) in non-Hodgkin's lymphoma cells
    • DOI 10.1038/sj.leu.2404723, PII 2404723
    • Lwin, T. et al. Bone marrow stromal cells prevent apoptosis of lymphoma cells by upregulation of anti-Apoptotic proteins associated with activation of NF κB (RelB/p52) in non-Hodgkins lymphoma cells. Leukemia 21, 1521-1531 (2007 (Pubitemid 46965295)
    • (2007) Leukemia , vol.21 , Issue.7 , pp. 1521-1531
    • Lwin, T.1    Hazlehurst, L.A.2    Li, Z.3    Dessureault, S.4    Sotomayor, E.5    Moscinski, L.C.6    Dalton, W.S.7    Tao, J.8
  • 115
    • 80052570271 scopus 로고    scopus 로고
    • Bone marrow stromal cells protect lymphoma B cells from rituximab-induced apoptosis and targeting integrin α-4 β-1 (VLA 4) with natalizumab can overcome this resistance
    • Mraz, M. et al. Bone marrow stromal cells protect lymphoma B cells from rituximab-induced apoptosis and targeting integrin α-4 β-1 (VLA 4) with natalizumab can overcome this resistance. Br. J. Haematol. 155, 53-64 (2011
    • (2011) Br. J. Haematol , vol.155 , pp. 53-64
    • Mraz, M.1
  • 116
    • 78650056617 scopus 로고    scopus 로고
    • Follicular dendritic cell-dependent drug resistance of non-Hodgkin lymphoma involves cell adhesion-mediated Bim down-regulation through induction of microRNA 181a
    • Lwin, T. et al. Follicular dendritic cell-dependent drug resistance of non-Hodgkin lymphoma involves cell adhesion-mediated Bim down-regulation through induction of microRNA 181a. Blood 116, 5228-5236 (2010
    • (2010) Blood , vol.116 , pp. 5228-5236
    • Lwin, T.1
  • 117
    • 84887421655 scopus 로고    scopus 로고
    • A microenvironment-mediated c Myc/ miR 548m/HDAC6 amplification loop in non-Hodgkin B cell lymphomas
    • Lwin, T. et al. A microenvironment-mediated c Myc/ miR 548m/HDAC6 amplification loop in non-Hodgkin B cell lymphomas. J. Clin. Invest. 123, 4612-4626 (2013
    • (2013) J. Clin. Invest , vol.123 , pp. 4612-4626
    • Lwin, T.1
  • 118
    • 34547137412 scopus 로고    scopus 로고
    • Skp2 ubiquitin ligase pathway in mantle-cell and other non-Hodgkin B-cell lymphomas
    • DOI 10.1182/blood-2006-11-060350
    • Lwin, T. et al. Cell adhesion induces p27Kip1 associated cell-cycle arrest through down-regulation of the SCFSkp2 ubiquitin ligase pathway in mantle-cell and other non-Hodgkin B cell lymphomas. Blood 110, 1631-1638 (2007 (Pubitemid 47443981)
    • (2007) Blood , vol.110 , Issue.5 , pp. 1631-1638
    • Lwin, T.1    Hazlehurst, L.A.2    Dessureault, S.3    Lai, R.4    Bai, W.5    Sotomayor, E.6    Moscinski, L.C.7    Dalton, W.S.8    Tao, J.9
  • 119
    • 0027213922 scopus 로고
    • Regression of primary low-grade-B-cell gastric lymphoma of mucosa-associated lymphoid tissue type after eradication of Helicobacter pylori
    • DOI 10.1016/0140-6736(93)91409-F
    • Wotherspoon, A. C. et al. Regression of primary low-grade B cell gastric lymphoma of mucosa-Associated lymphoid tissue type after eradication of Helicobacter pylori. Lancet 342, 575-577 (1993 (Pubitemid 23259233)
    • (1993) Lancet , vol.342 , Issue.8871 , pp. 575-577
    • Wotherspoon, A.C.1    Doglioni, C.2    Diss, T.C.3    Pan, L.4    Moschini, A.5    De Boni, M.6    Isaacson, P.G.7
  • 120
    • 79955806814 scopus 로고    scopus 로고
    • Active and passive immunotherapy for lymphoma: Proving principles and improving results
    • Brody, J., Kohrt, H., Marabelle, A. & Levy, R. Active and passive immunotherapy for lymphoma: Proving principles and improving results. J. Clin. Oncol. 29, 1864-1875 (2011
    • (2011) J. Clin. Oncol , vol.29 , pp. 1864-1875
    • Brody, J.1    Kohrt, H.2    Marabelle, A.3    Levy, R.4
  • 121
    • 84867870598 scopus 로고    scopus 로고
    • Novel therapy for therapy-resistant mantle cell lymphoma: Multipronged approach with targeting of hedgehog signaling
    • Hegde, G. V. et al. Novel therapy for therapy-resistant mantle cell lymphoma: Multipronged approach with targeting of hedgehog signaling. Int. J. Cancer 131, 2951-2960 (2012
    • (2012) Int. J. Cancer , vol.131 , pp. 2951-2960
    • Hegde, G.V.1
  • 122
    • 84871806385 scopus 로고    scopus 로고
    • Bruton tyrosine kinase inhibitor ibrutinib (PCI 32765) has significant activity in patients with relapsed/refractory B cell malignancies
    • Advani, R. H. et al. Bruton tyrosine kinase inhibitor ibrutinib (PCI 32765) has significant activity in patients with relapsed/refractory B cell malignancies. J. Clin. Oncol. 31, 88-94 (2013
    • (2013) J. Clin. Oncol , vol.31 , pp. 88-94
    • Advani, R.H.1
  • 123
    • 84893502903 scopus 로고    scopus 로고
    • Sensitizing protective tumor microenvironments to antibody-mediated therapy
    • Pallasch, C. P. et al. Sensitizing protective tumor microenvironments to antibody-mediated therapy. Cell 156, 590-602 (2014
    • (2014) Cell , vol.156 , pp. 590-602
    • Pallasch, C.P.1
  • 124
    • 0034648765 scopus 로고    scopus 로고
    • Angiogenesis in cancer and other diseases
    • Carmeliet, P. & Jain, R. K. Angiogenesis in cancer and other diseases. Nature 407, 249-257 (2000
    • (2000) Nature , vol.407 , pp. 249-257
    • Carmeliet, P.1    Jain, R.K.2
  • 125
    • 84874613534 scopus 로고    scopus 로고
    • The role of angiogenesis in human non-Hodgkin lymphomas
    • Ribatti, D., Nico, B., Ranieri, G., Specchia, G. & Vacca, A. The role of angiogenesis in human non-Hodgkin lymphomas. Neoplasia 15, 231-238 (2013
    • (2013) Neoplasia , vol.15 , pp. 231-238
    • Ribatti, D.1    Nico, B.2    Ranieri, G.3    Specchia, G.4    Vacca, A.5
  • 127
    • 37549055122 scopus 로고    scopus 로고
    • Prognostic significance of VEGF VEGF receptors and microvessel density in diffuse large B cell lymphoma treated with anthracycline-based chemotherapy
    • Gratzinger, D. et al. Prognostic significance of VEGF, VEGF receptors, and microvessel density in diffuse large B cell lymphoma treated with anthracycline-based chemotherapy. Lab Invest. 88, 38-47 (2008
    • (2008) Lab Invest , vol.88 , pp. 38-47
    • Gratzinger, D.1
  • 128
    • 72649103913 scopus 로고    scopus 로고
    • Lymphoma cell VEGFR2 expression detected by immunohistochemistry predicts poor overall survival in diffuse large B cell lymphoma treated with immunochemotherapy (R CHOP
    • Gratzinger, D. et al. Lymphoma cell VEGFR2 expression detected by immunohistochemistry predicts poor overall survival in diffuse large B cell lymphoma treated with immunochemotherapy (R CHOP). Br. J. Haematol. 148, 235-244 (2010
    • (2010) Br. J. Haematol , vol.148 , pp. 235-244
    • Gratzinger, D.1
  • 129
    • 84865168191 scopus 로고    scopus 로고
    • A phase 2 trial of standard-dose cyclophosphamide, doxorubicin, vincristine, prednisone (CHOP) and rituximab plus bevacizumab for patients with newly diagnosed diffuse large B cell non-Hodgkin lymphoma: SWOG 0515
    • Stopeck, A. T. et al. A phase 2 trial of standard-dose cyclophosphamide, doxorubicin, vincristine, prednisone (CHOP) and rituximab plus bevacizumab for patients with newly diagnosed diffuse large B cell non-Hodgkin lymphoma: SWOG 0515. Blood 120, 1210-1217 (2012
    • (2012) Blood , vol.120 , pp. 1210-1217
    • Stopeck, A.T.1
  • 130
    • 84884170348 scopus 로고    scopus 로고
    • Imatinib disrupts lymphoma angiogenesis by targeting vascular pericytes
    • Ruan, J. et al. Imatinib disrupts lymphoma angiogenesis by targeting vascular pericytes. Blood 121, 5192-5202 (2013
    • (2013) Blood , vol.121 , pp. 5192-5202
    • Ruan, J.1
  • 131
    • 84857478229 scopus 로고    scopus 로고
    • Targeting CXCR4 with cell-penetrating pepducins in lymphoma and lymphocytic leukemia
    • OCallaghan, K. et al. Targeting CXCR4 with cell-penetrating pepducins in lymphoma and lymphocytic leukemia. Blood 119, 1717-1725 (2012
    • (2012) Blood , vol.119 , pp. 1717-1725
    • Ocallaghan, K.1
  • 132
    • 84855458019 scopus 로고    scopus 로고
    • Enhancement of the anti-Tumor activity of therapeutic monoclonal antibodies by CXCR4 antagonists
    • Hu, Y. et al. Enhancement of the anti-Tumor activity of therapeutic monoclonal antibodies by CXCR4 antagonists. Leuk. Lymphoma 53, 130-138 (2012
    • (2012) Leuk. Lymphoma , vol.53 , pp. 130-138
    • Hu, Y.1
  • 133
    • 84876477884 scopus 로고    scopus 로고
    • Coming full circle: 70 years of chronic lymphocytic leukemia cell redistribution, from glucocorticoids to inhibitors of B cell receptor signaling
    • Burger, J. A. & Montserrat, E. Coming full circle: 70 years of chronic lymphocytic leukemia cell redistribution, from glucocorticoids to inhibitors of B cell receptor signaling. Blood 121, 1501-1509 (2013
    • (2013) Blood , vol.121 , pp. 1501-1509
    • Burger, J.A.1    Montserrat, E.2
  • 134
    • 84881225049 scopus 로고    scopus 로고
    • Targeting BTK with ibrutinib in relapsed or refractory mantle-cell lymphoma
    • Wang, M. L. et al. Targeting BTK with ibrutinib in relapsed or refractory mantle-cell lymphoma. N. Engl. J. Med. 369, 507-516 (2013
    • (2013) N. Engl. J. Med , vol.369 , pp. 507-516
    • Wang, M.L.1
  • 135
    • 84887695622 scopus 로고    scopus 로고
    • Egress of CD19+CD5+ cells into the peripheral blood following treatment with the Bruton tyrosine kinase inhibitor ibrutinib in mantle cell lymphoma patients
    • Chang, B. Y. et al. Egress of CD19+CD5+ cells into the peripheral blood following treatment with the Bruton tyrosine kinase inhibitor ibrutinib in mantle cell lymphoma patients. Blood 122, 2412-2424 (2013
    • (2013) Blood , vol.122 , pp. 2412-2424
    • Chang, B.Y.1
  • 136
    • 84895815322 scopus 로고    scopus 로고
    • Integrated genomic analysis identifies recurrent mutations and evolution patterns driving the initiation and progression of follicular lymphoma
    • Okosun, J. et al. Integrated genomic analysis identifies recurrent mutations and evolution patterns driving the initiation and progression of follicular lymphoma. Nature Genet. 46, 176-181 (2013
    • (2013) Nature Genet , vol.46 , pp. 176-181
    • Okosun, J.1
  • 137
    • 84892553514 scopus 로고    scopus 로고
    • Genetics of follicular lymphoma transformation
    • Pasqualucci, L. et al. Genetics of follicular lymphoma transformation. Cell Rep. 6, 130-140 (2014
    • (2014) Cell Rep , vol.6 , pp. 130-140
    • Pasqualucci, L.1
  • 138
    • 0242551584 scopus 로고    scopus 로고
    • Homing and cellular traffic in lymph nodes
    • Von Andrian, U. H. & Mempel, T. R. Homing and cellular traffic in lymph nodes. Nature Rev. Immunol. 3, 867-878 (2003 (Pubitemid 37411716)
    • (2003) Nature Reviews Immunology , vol.3 , Issue.11 , pp. 867-878
    • Von Andrian, U.H.1    Mempel, T.R.2
  • 139
    • 70249085585 scopus 로고    scopus 로고
    • Stromal cell contributions to the homeostasis and functionality of the immune system
    • Mueller, S. N. & Germain, R. N. Stromal cell contributions to the homeostasis and functionality of the immune system. Nature Rev. Immunol. 9, 618-629 (2009
    • (2009) Nature Rev. Immunol , vol.9 , pp. 618-629
    • Mueller, S.N.1    Germain, R.N.2
  • 140
    • 58149097584 scopus 로고    scopus 로고
    • The who, how and where of antigen presentation to B cells
    • Batista, F. D. & Harwood, N. E. The who, how and where of antigen presentation to B cells. Nature Rev. Immunol. 9, 15-27 (2009
    • (2009) Nature Rev. Immunol , vol.9 , pp. 15-27
    • Batista, F.D.1    Harwood, N.E.2
  • 142
    • 79958255209 scopus 로고    scopus 로고
    • A dynamic T cell-limited checkpoint regulates affinity-dependent B cell entry into the germinal center
    • Schwickert, T. A. et al. A dynamic T cell-limited checkpoint regulates affinity-dependent B cell entry into the germinal center. J. Exp. Med. 208, 1243-1252 (2011
    • (2011) J. Exp. Med , vol.208 , pp. 1243-1252
    • Schwickert, T.A.1
  • 143
    • 84867730760 scopus 로고    scopus 로고
    • The cell-cycle regulator c Myc is essential for the formation and maintenance of germinal centers
    • Calado, D. P. et al. The cell-cycle regulator c Myc is essential for the formation and maintenance of germinal centers. Nature Immunol. 13, 1092-1100 (2012
    • (2012) Nature Immunol , vol.13 , pp. 1092-1100
    • Calado, D.P.1
  • 144
    • 84867709361 scopus 로고    scopus 로고
    • The proto-oncogene MYC is required for selection in the germinal center and cyclic reentry
    • Dominguez-Sola, D. et al. The proto-oncogene MYC is required for selection in the germinal center and cyclic reentry. Nature Immunol. 13, 1083-1091 (2012
    • (2012) Nature Immunol , vol.13 , pp. 1083-1091
    • Dominguez-Sola, D.1
  • 145
    • 78149477766 scopus 로고    scopus 로고
    • Germinal center dynamics revealed by multiphoton microscopy with a photoactivatable fluorescent reporter
    • Victora, G. D. et al. Germinal center dynamics revealed by multiphoton microscopy with a photoactivatable fluorescent reporter. Cell 143, 592-605 (2010
    • (2010) Cell , vol.143 , pp. 592-605
    • Victora, G.D.1
  • 146
    • 84901644301 scopus 로고    scopus 로고
    • Clonal selection in the germinal centre by regulated proliferation and hypermutation
    • Gitlin, A. D., Shulman, Z. & Nussenzweig, M. C. Clonal selection in the germinal centre by regulated proliferation and hypermutation. Nature 509, 637-640 (2014
    • (2014) Nature , vol.509 , pp. 637-640
    • Gitlin, A.D.1    Shulman, Z.2    Nussenzweig, M.C.3
  • 148
    • 84867163670 scopus 로고    scopus 로고
    • Molecular pathogenesis of mantle cell lymphoma
    • Jares, P., Colomer, D. & Campo, E. Molecular pathogenesis of mantle cell lymphoma. J. Clin. Invest. 122, 3416-3423 (2012
    • (2012) J. Clin. Invest , vol.122 , pp. 3416-3423
    • Jares, P.1    Colomer, D.2    Campo, E.3
  • 150
    • 84866320759 scopus 로고    scopus 로고
    • Identification of human germinal center light and dark zone cells and their relationship to human B cell lymphomas
    • Victora, G. D. et al. Identification of human germinal center light and dark zone cells and their relationship to human B cell lymphomas. Blood 120, 2240-2248 (2012
    • (2012) Blood , vol.120 , pp. 2240-2248
    • Victora, G.D.1
  • 151
    • 0025935635 scopus 로고
    • Helicobacter pylori-Associated gastritis and primary B cell gastric lymphoma
    • Wotherspoon, A. C., Ortiz-Hidalgo, C., Falzon, M. R. & Isaacson, P. G. Helicobacter pylori-Associated gastritis and primary B cell gastric lymphoma. Lancet 338, 1175-1176 (1991
    • (1991) Lancet , vol.338 , pp. 1175-1176
    • Wotherspoon, A.C.1    Ortiz-Hidalgo, C.2    Falzon, M.R.3    Isaacson, P.G.4
  • 152
    • 0030045265 scopus 로고    scopus 로고
    • Helicobacter pylori-specific tumour-infiltrating T cells provide contact dependent help for the growth of malignant B cells in low-grade gastric lymphoma of mucosa-Associated lymphoid tissue
    • Hussell, T., Isaacson, P. G., Crabtree, J. E. & Spencer, J. Helicobacter pylori-specific tumour-infiltrating T cells provide contact dependent help for the growth of malignant B cells in low-grade gastric lymphoma of mucosa-Associated lymphoid tissue. J. Pathol. 178, 122-127 (1996
    • (1996) J. Pathol , vol.178 , pp. 122-127
    • Hussell, T.1    Isaacson, P.G.2    Crabtree, J.E.3    Spencer, J.4
  • 153
    • 3543066288 scopus 로고    scopus 로고
    • MALT lymphoma: From morphology to molecules
    • Isaacson, P. G. & Du, M. Q. MALT lymphoma: From morphology to molecules. Nature Rev. Cancer 4, 644-653 (2004 (Pubitemid 39025059)
    • (2004) Nature Reviews Cancer , vol.4 , Issue.8 , pp. 644-653
    • Isaacson, P.G.1    Du, M.-Q.2
  • 154
    • 84857942952 scopus 로고    scopus 로고
    • Discovery and prioritization of somatic mutations in diffuse large B cell lymphoma (DLBCL) by whole-exome sequencing
    • Lohr, J. G. et al. Discovery and prioritization of somatic mutations in diffuse large B cell lymphoma (DLBCL) by whole-exome sequencing. Proc. Natl Acad. Sci. USA 109, 3879-3884 (2012
    • (2012) Proc. Natl Acad. Sci. USA , vol.109 , pp. 3879-3884
    • Lohr, J.G.1
  • 155
    • 84872856782 scopus 로고    scopus 로고
    • Genetic heterogeneity of diffuse large B cell lymphoma
    • Zhang, J. et al. Genetic heterogeneity of diffuse large B cell lymphoma. Proc. Natl Acad. Sci. USA 110, 1398-1403 (2013
    • (2013) Proc. Natl Acad. Sci. USA , vol.110 , pp. 1398-1403
    • Zhang, J.1
  • 156
    • 84876460347 scopus 로고    scopus 로고
    • Hierarchy in somatic mutations arising during genomic evolution and progression of follicular lymphoma
    • Green, M. R. et al. Hierarchy in somatic mutations arising during genomic evolution and progression of follicular lymphoma. Blood 121, 1604-1611 (2013
    • (2013) Blood , vol.121 , pp. 1604-1611
    • Green, M.R.1
  • 157
    • 84887285547 scopus 로고    scopus 로고
    • Landscape of somatic mutations and clonal evolution in mantle cell lymphoma
    • Bea, S. et al. Landscape of somatic mutations and clonal evolution in mantle cell lymphoma. Proc. Natl Acad. Sci. USA 110, 18250-18255 (2013
    • (2013) Proc. Natl Acad. Sci. USA , vol.110 , pp. 18250-18255
    • Bea, S.1
  • 158
    • 84866392764 scopus 로고    scopus 로고
    • Whole-genome sequencing identifies recurrent somatic NOTCH2 mutations in splenic marginal zone lymphoma
    • Kiel, M. J. et al. Whole-genome sequencing identifies recurrent somatic NOTCH2 mutations in splenic marginal zone lymphoma. J. Exp. Med. 209, 1553-1565 (2012
    • (2012) J. Exp. Med , vol.209 , pp. 1553-1565
    • Kiel, M.J.1
  • 159
    • 84870544677 scopus 로고    scopus 로고
    • Recurrent mutation of the ID3 gene in Burkitt lymphoma identified by integrated genome, exome and transcriptome sequencing
    • Richter, J. et al. Recurrent mutation of the ID3 gene in Burkitt lymphoma identified by integrated genome, exome and transcriptome sequencing. Nature Genet. 44, 1316-1320 (2012
    • (2012) Nature Genet , vol.44 , pp. 1316-1320
    • Richter, J.1
  • 160
    • 84870538715 scopus 로고    scopus 로고
    • The genetic landscape of mutations in Burkitt lymphoma
    • Love, C. et al. The genetic landscape of mutations in Burkitt lymphoma. Nature Genet. 44, 1321-1325 (2012
    • (2012) Nature Genet , vol.44 , pp. 1321-1325
    • Love, C.1
  • 164
    • 84860713220 scopus 로고    scopus 로고
    • Denileukin diftitox in combination with rituximab for previously untreated follicular B cell non-Hodgkins lymphoma
    • Ansell, S. M. et al. Denileukin diftitox in combination with rituximab for previously untreated follicular B cell non-Hodgkins lymphoma. Leukemia 26, 1046-1052 (2012
    • (2012) Leukemia , vol.26 , pp. 1046-1052
    • Ansell, S.M.1
  • 166
    • 70350244852 scopus 로고    scopus 로고
    • Phase i study of ipilimumab, an anti-CTLA 4 monoclonal antibody, in patients with relapsed and refractory B cell non-Hodgkin lymphoma
    • Ansell, S. M. et al. Phase I study of ipilimumab, an anti-CTLA 4 monoclonal antibody, in patients with relapsed and refractory B cell non-Hodgkin lymphoma. Clin. Cancer Res. 15, 6446-6453 (2009
    • (2009) Clin. Cancer Res , vol.15 , pp. 6446-6453
    • Ansell, S.M.1
  • 167
    • 61849165013 scopus 로고    scopus 로고
    • CTLA4 blockade with ipilimumab to treat relapse of malignancy after allogeneic hematopoietic cell transplantation
    • Bashey, A. et al. CTLA4 blockade with ipilimumab to treat relapse of malignancy after allogeneic hematopoietic cell transplantation. Blood 113, 1581-1588 (2009
    • (2009) Blood , vol.113 , pp. 1581-1588
    • Bashey, A.1
  • 168
    • 33847407907 scopus 로고    scopus 로고
    • A pilot study of CTLA 4 blockade after cancer vaccine failure in patients with advanced malignancy
    • OMahony, D. et al. A pilot study of CTLA 4 blockade after cancer vaccine failure in patients with advanced malignancy. Clin. Cancer Res. 13, 958-964 (2007
    • (2007) Clin. Cancer Res , vol.13 , pp. 958-964
    • Omahony, D.1
  • 169
    • 49649114804 scopus 로고    scopus 로고
    • Phase i safety and pharmacokinetic study of CT 011, a humanized antibody interacting with PD 1, in patients with advanced hematologic malignancies
    • Berger, R. et al. Phase I safety and pharmacokinetic study of CT 011, a humanized antibody interacting with PD 1, in patients with advanced hematologic malignancies. Clin. Cancer Res. 14, 3044-3051 (2008
    • (2008) Clin. Cancer Res , vol.14 , pp. 3044-3051
    • Berger, R.1
  • 170
    • 84890096527 scopus 로고    scopus 로고
    • Disabling immune tolerance by programmed death 1 blockade with pidilizumab after autologous hematopoietic stem-cell transplantation for diffuse large B cell lymphoma: Results of an international phase II trial
    • Armand, P. et al. Disabling immune tolerance by programmed death 1 blockade with pidilizumab after autologous hematopoietic stem-cell transplantation for diffuse large B cell lymphoma: Results of an international phase II trial. J. Clin. Oncol. 31, 4199-4206 (2013
    • (2013) J. Clin. Oncol , vol.31 , pp. 4199-4206
    • Armand, P.1
  • 171
    • 84891373595 scopus 로고    scopus 로고
    • Safety and activity of PD1 blockade by pidilizumab in combination with rituximab in patients with relapsed follicular lymphoma: A single group, open-label, phase 2 trial
    • Westin, J. R. et al. Safety and activity of PD1 blockade by pidilizumab in combination with rituximab in patients with relapsed follicular lymphoma: A single group, open-label, phase 2 trial. Lancet Oncol. 15, 69-77 (2014
    • (2014) Lancet Oncol , vol.15 , pp. 69-77
    • Westin, J.R.1
  • 172
    • 84860712523 scopus 로고    scopus 로고
    • Phase 2 study of rituximab plus ABVD in patients with newly diagnosed classical Hodgkin lymphoma
    • Younes, A. et al. Phase 2 study of rituximab plus ABVD in patients with newly diagnosed classical Hodgkin lymphoma. Blood 119, 4123-4128 (2012
    • (2012) Blood , vol.119 , pp. 4123-4128
    • Younes, A.1
  • 173
    • 84860741107 scopus 로고    scopus 로고
    • Phase 2 study of rituximab-ABVD in classical Hodgkin lymphoma
    • Kasamon, Y. L. et al. Phase 2 study of rituximab-ABVD in classical Hodgkin lymphoma. Blood 119, 4129-4132 (2012
    • (2012) Blood , vol.119 , pp. 4129-4132
    • Kasamon, Y.L.1
  • 175
    • 54449095901 scopus 로고    scopus 로고
    • Lenalidomide monotherapy in relapsed or refractory aggressive non-Hodgkins lymphoma
    • Wiernik, P. H. et al. Lenalidomide monotherapy in relapsed or refractory aggressive non-Hodgkins lymphoma. J. Clin. Oncol. 26, 4952-4957 (2008
    • (2008) J. Clin. Oncol , vol.26 , pp. 4952-4957
    • Wiernik, P.H.1
  • 176
    • 64149112784 scopus 로고    scopus 로고
    • Lenalidomide oral monotherapy produces a high response rate in patients with relapsed or refractory mantle cell lymphoma
    • Habermann, T. M. et al. Lenalidomide oral monotherapy produces a high response rate in patients with relapsed or refractory mantle cell lymphoma. Br. J. Haematol. 145, 344-349 (2009
    • (2009) Br. J. Haematol , vol.145 , pp. 344-349
    • Habermann, T.M.1
  • 177
    • 73949145763 scopus 로고    scopus 로고
    • Lenalidomide oral monotherapy produces durable responses in relapsed or refractory indolent non-Hodgkins lymphoma
    • Witzig, T. E. et al. Lenalidomide oral monotherapy produces durable responses in relapsed or refractory indolent non-Hodgkins lymphoma. J. Clin. Oncol. 27, 5404-5409 (2009
    • (2009) J. Clin. Oncol , vol.27 , pp. 5404-5409
    • Witzig, T.E.1
  • 178
    • 79959722615 scopus 로고    scopus 로고
    • An international phase II trial of single-Agent lenalidomide for relapsed or refractory aggressive B cell non-Hodgkins lymphoma
    • Witzig, T. E. et al. An international phase II trial of single-Agent lenalidomide for relapsed or refractory aggressive B cell non-Hodgkins lymphoma. Ann. Oncol. 22, 1622-1627 (2011
    • (2011) Ann. Oncol , vol.22 , pp. 1622-1627
    • Witzig, T.E.1
  • 179
    • 84887030194 scopus 로고    scopus 로고
    • Long-Term follow up of lenalidomide in relapsed/refractory mantle cell lymphoma: Subset analysis of the NHL 003 study
    • Zinzani, P. L. et al. Long-Term follow up of lenalidomide in relapsed/refractory mantle cell lymphoma: Subset analysis of the NHL 003 study. Ann. Oncol. 24, 2892-2897 (2013
    • (2013) Ann. Oncol , vol.24 , pp. 2892-2897
    • Zinzani, P.L.1
  • 180
    • 84866875871 scopus 로고    scopus 로고
    • Single-Agent lenalidomide in relapsed/ refractory mantle cell lymphoma: Results from a UK phase II study suggest activity and possible gender differences
    • Eve, H. E. et al. Single-Agent lenalidomide in relapsed/ refractory mantle cell lymphoma: Results from a UK phase II study suggest activity and possible gender differences. Br. J. Haematol. 159, 154-163 (2012
    • (2012) Br. J. Haematol , vol.159 , pp. 154-163
    • Eve, H.E.1
  • 181
    • 84889099537 scopus 로고    scopus 로고
    • Single-Agent lenalidomide in patients with mantle-cell lymphoma who relapsed or progressed after or were refractory to bortezomib: Phase II MCL 001 (EMERGE) study
    • Goy, A. et al. Single-Agent lenalidomide in patients with mantle-cell lymphoma who relapsed or progressed after or were refractory to bortezomib: Phase II MCL 001 (EMERGE) study. J. Clin. Oncol. 31, 3688-3695 (2013
    • (2013) J. Clin. Oncol , vol.31 , pp. 3688-3695
    • Goy, A.1
  • 182
    • 84874539200 scopus 로고    scopus 로고
    • A phase II study of lenalidomide in patients with extranodal marginal zone B cell lymphoma of the mucosa associated lymphoid tissue (MALT lymphoma
    • Kiesewetter, B. et al. A phase II study of lenalidomide in patients with extranodal marginal zone B cell lymphoma of the mucosa associated lymphoid tissue (MALT lymphoma). Haematologica 98, 353-356 (2013
    • (2013) Haematologica , vol.98 , pp. 353-356
    • Kiesewetter, B.1
  • 183
    • 81055123994 scopus 로고    scopus 로고
    • A phase 2 multicenter study of lenalidomide in relapsed or refractory classical Hodgkin lymphoma
    • Fehniger, T. A. et al. A phase 2 multicenter study of lenalidomide in relapsed or refractory classical Hodgkin lymphoma. Blood 118, 5119-5125 (2011
    • (2011) Blood , vol.118 , pp. 5119-5125
    • Fehniger, T.A.1
  • 184
    • 84857740069 scopus 로고    scopus 로고
    • Salvage treatment with lenalidomide and dexamethasone in relapsed/refractory mantle cell lymphoma: Clinical results and effects on microenvironment and neo-Angiogenic biomarkers
    • Zaja, F. et al. Salvage treatment with lenalidomide and dexamethasone in relapsed/refractory mantle cell lymphoma: Clinical results and effects on microenvironment and neo-Angiogenic biomarkers. Haematologica 97, 416-422 (2012
    • (2012) Haematologica , vol.97 , pp. 416-422
    • Zaja, F.1
  • 185
    • 84863107308 scopus 로고    scopus 로고
    • Lenalidomide in combination with rituximab for patients with relapsed or refractory mantle-cell lymphoma: A phase 1/2 clinical trial
    • Wang, M. et al. Lenalidomide in combination with rituximab for patients with relapsed or refractory mantle-cell lymphoma: A phase 1/2 clinical trial. Lancet Oncol. 13, 716-723 (2012
    • (2012) Lancet Oncol , vol.13 , pp. 716-723
    • Wang, M.1
  • 186
    • 84857654592 scopus 로고    scopus 로고
    • Combination of lenalidomide and rituximab in elderly patients with relapsed or refractory diffuse large B cell lymphoma: A phase 2 trial
    • Zinzani, P. L. et al. Combination of lenalidomide and rituximab in elderly patients with relapsed or refractory diffuse large B cell lymphoma: A phase 2 trial. Clin. Lymphoma Myeloma Leuk. 11, 462-466 (2011
    • (2011) Clin. Lymphoma Myeloma Leuk , vol.11 , pp. 462-466
    • Zinzani, P.L.1
  • 187
    • 84883742025 scopus 로고    scopus 로고
    • Oral lenalidomide with rituximab in relapsed or refractory diffuse large cell, follicular and transformed lymphoma: A phase II clinical trial
    • Wang, M. et al. Oral lenalidomide with rituximab in relapsed or refractory diffuse large cell, follicular and transformed lymphoma: A phase II clinical trial. Leukemia 27, 1902-1909 (2013
    • (2013) Leukemia , vol.27 , pp. 1902-1909
    • Wang, M.1
  • 188
    • 84891868901 scopus 로고    scopus 로고
    • Combined lenalidomide, low-dose dexamethasone, and rituximab achieves durable responses in rituximab-resistant indolent and mantle cell lymphomas
    • Ahmadi, T. et al. Combined lenalidomide, low-dose dexamethasone, and rituximab achieves durable responses in rituximab-resistant indolent and mantle cell lymphomas. Cancer 120, 222-228 (2014
    • (2014) Cancer , vol.120 , pp. 222-228
    • Ahmadi, T.1
  • 189
    • 83555173455 scopus 로고    scopus 로고
    • Lenalidomide can be safely combined with R CHOP (R2CHOP) in the initial chemotherapy for aggressive B cell lymphomas: Phase i study
    • Nowakowski, G. S. et al. Lenalidomide can be safely combined with R CHOP (R2CHOP) in the initial chemotherapy for aggressive B cell lymphomas: Phase I study. Leukemia 25, 1877-1881 (2011
    • (2011) Leukemia , vol.25 , pp. 1877-1881
    • Nowakowski, G.S.1
  • 190
    • 84873571469 scopus 로고    scopus 로고
    • Phase Ib study of lenalidomide in combination with rituximab-CHOP (R2 CHOP) in patients with B cell lymphoma
    • Tilly, H. et al. Phase Ib study of lenalidomide in combination with rituximab-CHOP (R2 CHOP) in patients with B cell lymphoma. Leukemia 27, 252-255 (2013
    • (2013) Leukemia , vol.27 , pp. 252-255
    • Tilly, H.1
  • 191
    • 84887011781 scopus 로고    scopus 로고
    • Lenalidomide plus cyclophosphamide, doxorubicin, vincristine, prednisone and rituximab is safe and effective in untreated, elderly patients with diffuse large B cell lymphoma: A phase i study by the Fondazione Italiana Linfomi
    • Chiappella, A. et al. Lenalidomide plus cyclophosphamide, doxorubicin, vincristine, prednisone and rituximab is safe and effective in untreated, elderly patients with diffuse large B cell lymphoma: A phase I study by the Fondazione Italiana Linfomi. Haematologica 98, 1732-1738 (2013
    • (2013) Haematologica , vol.98 , pp. 1732-1738
    • Chiappella, A.1
  • 192
    • 67650866822 scopus 로고    scopus 로고
    • A phase II trial of single agent bevacizumab in patients with relapsed, aggressive non-Hodgkin lymphoma: Southwest oncology group study S0108
    • Stopeck, A. T. et al. A phase II trial of single agent bevacizumab in patients with relapsed, aggressive non-Hodgkin lymphoma: Southwest oncology group study S0108. Leuk. Lymphoma 50, 728-735 (2009
    • (2009) Leuk. Lymphoma , vol.50 , pp. 728-735
    • Stopeck, A.T.1
  • 193
    • 84896395732 scopus 로고    scopus 로고
    • Long-Term follow up of R CHOP with bevacizumab as initial therapy for mantle cell lymphoma: Clinical and correlative results
    • Ruan, J. et al. Long-Term follow up of R CHOP with bevacizumab as initial therapy for mantle cell lymphoma: Clinical and correlative results. Clin. Lymphoma Myeloma Leuk. 14, 107-113 (2014
    • (2014) Clin. Lymphoma Myeloma Leuk , vol.14 , pp. 107-113
    • Ruan, J.1
  • 194
    • 33646719056 scopus 로고    scopus 로고
    • Mechanisms and effects of loss of human leukocyte antigen class II expression in immune-privileged site-Associated B cell lymphoma
    • Booman, M. et al. Mechanisms and effects of loss of human leukocyte antigen class II expression in immune-privileged site-Associated B cell lymphoma. Clin. Cancer Res. 12, 2698-2705 (2006
    • (2006) Clin. Cancer Res , vol.12 , pp. 2698-2705
    • Booman, M.1
  • 195
    • 79960297332 scopus 로고    scopus 로고
    • Primary central nervous system lymphomas: A validation study of array-based comparative genomic hybridization in formalin-fixed paraffin-embedded tumor specimens
    • Braggio, E. et al. Primary central nervous system lymphomas: A validation study of array-based comparative genomic hybridization in formalin-fixed paraffin-embedded tumor specimens. Clin. Cancer Res. 17, 4245-4253 (2011
    • (2011) Clin. Cancer Res , vol.17 , pp. 4245-4253
    • Braggio, E.1
  • 196
    • 79251573226 scopus 로고    scopus 로고
    • Genomic profiling combined with gene expression profiling in primary central nervous system lymphoma
    • Sung, C. O. et al. Genomic profiling combined with gene expression profiling in primary central nervous system lymphoma. Blood 117, 1291-1300 (2011
    • (2011) Blood , vol.117 , pp. 1291-1300
    • Sung, C.O.1
  • 197
    • 84897530680 scopus 로고    scopus 로고
    • Genomic rearrangements involving programmed death ligands are recurrent in primary mediastinal large B cell lymphoma
    • Twa, D. D. et al. Genomic rearrangements involving programmed death ligands are recurrent in primary mediastinal large B cell lymphoma. Blood 123, 2062-2065 (2014
    • (2014) Blood , vol.123 , pp. 2062-2065
    • Twa, D.D.1
  • 198
    • 77953526533 scopus 로고    scopus 로고
    • High resolution analysis of follicular lymphoma genomes reveals somatic recurrent sites of copy-neutral loss of heterozygosity and copy number alterations that target single genes
    • Cheung, K. J. J. et al. High resolution analysis of follicular lymphoma genomes reveals somatic recurrent sites of copy-neutral loss of heterozygosity and copy number alterations that target single genes. Genes Chromosome Cancer 49, 669-681 (2010
    • (2010) Genes Chromosome Cancer , vol.49 , pp. 669-681
    • Cheung, K.J.J.1
  • 199
    • 78549281806 scopus 로고    scopus 로고
    • Acquired TNFRSF14 mutations in follicular lymphoma are associated with worse prognosis
    • Cheung, K. J. et al. Acquired TNFRSF14 mutations in follicular lymphoma are associated with worse prognosis. Cancer Res. 70, 9166-9174 (2010
    • (2010) Cancer Res , vol.70 , pp. 9166-9174
    • Cheung, K.J.1
  • 200
    • 84886290682 scopus 로고    scopus 로고
    • Mutational and structural analysis of diffuse large B cell lymphoma using whole genome sequencing
    • Morin, R. D. et al. Mutational and structural analysis of diffuse large B cell lymphoma using whole genome sequencing. Blood 122, 1256-1265 (2013
    • (2013) Blood , vol.122 , pp. 1256-1265
    • Morin, R.D.1
  • 201
    • 79959377393 scopus 로고    scopus 로고
    • The sphingosine 1 phosphate receptor S1P2 maintains the homeostasis of germinal center B cells and promotes niche confinement
    • Green, J. A. et al. The sphingosine 1 phosphate receptor S1P2 maintains the homeostasis of germinal center B cells and promotes niche confinement. Nature Immunol. 12, 672-680 (2011
    • (2011) Nature Immunol , vol.12 , pp. 672-680
    • Green, J.A.1
  • 202
    • 72249096210 scopus 로고    scopus 로고
    • Targeted disruption of the S1P2 sphingosine 1 phosphate receptor gene leads to diffuse large B cell lymphoma formation
    • Cattoretti, G. et al. Targeted disruption of the S1P2 sphingosine 1 phosphate receptor gene leads to diffuse large B cell lymphoma formation. Cancer Res. 69, 8686-8692 (2009
    • (2009) Cancer Res , vol.69 , pp. 8686-8692
    • Cattoretti, G.1
  • 203
    • 80155148301 scopus 로고    scopus 로고
    • The Eph-receptor A7 is a soluble tumor suppressor for follicular lymphoma
    • Oricchio, E. et al. The Eph-receptor A7 is a soluble tumor suppressor for follicular lymphoma. Cell 147, 554-564 (2011
    • (2011) Cell , vol.147 , pp. 554-564
    • Oricchio, E.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.